Healthcare Industry News: BD
News Release - September 29, 2006
Abbott to Provide a Free Blood Glucose Monitoring System to All Becton, Dickinson BD Logic(R) PatientsALAMEDA, Calif., Sept. 29 (HSMN NewsFeed) -- Abbott (NYSE: ABT ) today announced it will provide a free Abbott blood glucose meter and a starter supply of strips to all Becton, Dickinson and Company blood glucose monitoring patients using BD Logic® meters and test strips. Abbott made this decision after Becton, Dickinson's announcement that it intends to exit the blood glucose monitoring market by the end of 2007.
"People with diabetes using BD Logic blood glucose meters and strips are going to need an alternative for the short and long term and Abbott is pleased to assist BD Logic patients so they can effectively manage their diabetes now and in the future," said Ed Fiorentino, president, Abbott Diabetes Care. "We hope to alleviate any concern these patients may have by providing them with their choice of any one of our leading Abbott blood glucose monitoring systems."
Abbott's FreeStyle® line of blood glucose meters are most similar to BD Logic in that both blood glucose monitoring systems require a very small blood sample size, just 0.3 microliters, and offer fast test times. Becton, Dickinson's BD Logic users may call Abbott's toll-free customer care number 1- 888-208-2550 to obtain any of Abbott's blood glucose monitoring systems available in the United States and Canada which include FreeStyle Freedom(TM), FreeStyle Flash® (FreeStyle Mini® in Canada) and Precision Xtra(TM). In addition, patients will have the opportunity to enroll in Abbott's Friends for Life(TM) program, providing them with lifetime warranties on their meters, free lifetime upgrades to new Abbott blood glucose meters, an insurance helpline and diabetes educational support materials.
About Abbott Diabetes Care
Abbott Diabetes Care, based in Alameda, California, is a worldwide leader in developing, manufacturing and marketing glucose monitoring systems designed to help patients better manage their diabetes. Abbott Diabetes Care is committed to developing products to reduce the discomfort and inconvenience of blood glucose monitoring and introducing systems that are easier to use, require smaller blood samples and provide faster results.
Abbott Diabetes Care has several leading-edge glucose monitoring systems and test strips in the United States for use in both home and hospital settings; leading brands include FreeStyle Flash®, FreeStyle Freedom(TM) and Precision Xtra(TM). Additional information about Abbott Diabetes Care may be found at http://www.abbottdiabetescare.com .
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com .
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsAbbott Receives FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity(TM) i System
Abbott's TriClip(TM) Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav(TM) Delivery System for the Company's Portico(TM) Valve